论文部分内容阅读
目的:探讨CT引导下放射性125I粒子组织间植入治疗复发宫颈癌的疗效。方法:分析复发宫颈癌患者60例临床资料,依据治疗方式不同分为治疗Ⅰ组30例和治疗Ⅱ组30例;治疗Ⅰ组常规MVP方案,治疗Ⅱ组在常规化疗同时实施CT引导下放射性125I粒子组织间植入治疗。结果:治疗Ⅱ组复发宫颈癌患者的生活质量评分明显优于治疗Ⅰ组,治疗Ⅱ组复发宫颈癌患者1、3、5年生存率均优于治疗Ⅰ组,差异均有统计学意义(P<0.05)。结论:CT引导下放射性125I粒子组织间植入治疗复发宫颈癌的近期疗效和远期疗效均较明显,为临床上更加有效的治疗复发宫颈癌提供可靠的理论依据。
Objective: To investigate the curative effect of CT-guided 125I seed implantation in the treatment of recurrent cervical cancer. Methods: The clinical data of 60 patients with recurrent cervical cancer were analyzed. According to the different treatment methods, they were divided into treatment group (30 cases) and treatment group (30 cases). The patients in group Ⅰ received routine MVP regimen. Particle tissue implantation therapy. Results: The quality of life of patients with recurrent cervical cancer in group Ⅱ was significantly better than that in group Ⅰ. The 1, 3 and 5-year survival rates of patients in group Ⅱ with recurrent cervical cancer were significantly higher than those in group Ⅰ (P <0.05). CONCLUSION: The short-term and long-term curative effects of CT guided 125I seed implantation in the treatment of recurrent cervical cancer are obvious, which provide a reliable theoretical basis for more effective treatment of recurrent cervical cancer.